NCT05378399View on ClinicalTrials.gov

SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

March 20, 2026

Study Completion Date

March 31, 2026

Conditions
HIV InfectionsSubstance UseAdherence, MedicationAdherence, Treatment
Interventions
DRUG

Descovy or Truvada

Descovy or Truvada prescribed with digital pills for PrEP

DEVICE

ID-Cap System

Digital pills overencapsulating Descovy or Truvada for PrEP

DEVICE

Beiwe

Digital phenotyping app

Trial Locations (1)

02215

RECRUITING

Fenway Health, Boston

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

The Fenway Institute

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT05378399 - SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder | Biotech Hunter | Biotech Hunter